Abstract
Contact tracing (also known as partner notification) is a primary means of controlling infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), and sexually transmitted diseases (STDs). However, little work has been done to determine the optimal level of investment in contact tracing. In this paper, we present a methodology for evaluating the appropriate level of investment in contact tracing. We develop and apply a simulation model of contact tracing and the spread of an infectious disease among a network of individuals in order to evaluate the cost and effectiveness of different levels of contact tracing. We show that contact tracing is likely to have diminishing returns to scale in investment: incremental investments in contact tracing yield diminishing reductions in disease prevalence. In conjunction with a cost-effectiveness threshold, we then determine the optimal amount that should be invested in contact tracing. We first assume that the only incremental disease control is contact tracing. We then extend the analysis to consider the optimal allocation of a budget between contact tracing and screening for exogenous infection, and between contact tracing and screening for endogenous infection. We discuss how a simulation model of this type, appropriately tailored, could be used as a policy tool for determining the appropriate level of investment in contact tracing for a specific disease in a specific population. We present an example application to contact tracing for chlamydia control.
Article PDF
Similar content being viewed by others
References
Saretok P, Brouwers L (2007) Microsimulation of pandemic influenza in Sweden. In: Proceedings of the 2007 western multiconference on computer simulation, pp 73–78
Bozzette SA, Boer R, Bhatnagar V, Brower JL, Keeler EB, Morton SC, Stoto MA (2003) A model for a smallpox-vaccination policy. N Engl J Med 348(5):416–425
Hethcote HW (1982) Gonorrhea modeling: a comparison of control methods. Math Biosci 58:93–109
Zaric GS, Brandeau ML (2001) Resource allocation for epidemic control over short time horizons. Math Biosci 171:33–58
Zaric GS, Brandeau ML (2002) Dynamic resource allocation for epidemic control in multiple populations. IMA J Math Appl Med Biol 19:235–255
Longini IM Jr, Ackerman E, Elveback L (1978) An optimization model for influenza A epidemics. Math Biosci 38:141–157
Halloran ME, Longini IM Jr, Nizam A, Yang Y (2002) Containing bioterrorist smallpox. Science 298(5597):1428–1432
Müller J (1998) Optimal vaccination patterns in age-structured populations. SIAM J Appl Math 59:222–241
Revelle C, Feldmann F, Lynn W (1969) An optimization model tuberculosis epidemiology. Manage Sci 16(4):B190–B211
Centers for Disease Control and Prevention (2000) Chapter 10—community TB control: identification of persons who have clinically active TB, 2000. URL: http://www.cdc.gov/nchstp/tb/pubs/corecurr/Chapter10/Chapter_10_Identification.htm
Centers for Disease Control and Prevention (2002) Sexually transmitted diseases treatment guidelines 2002. URL: http://www.cdc.gov/STD/treatment/1-2002TG.htm
Cowan FM, French R, Johnson AM (1996) The role and effectiveness of partner notification in STD control: a review. Genitourin Med 72:247–252
Clarke J (1998) Contact tracing for chlamydia: data on effectiveness. Int J STD AIDS 9:187–191
Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science 300(5627):1966–1970
Kiss IZ, Green DM, Kao RR (2005) Disease contact tracing in random and clustered networks. Proc R Soc Lond B Biol Sci 272:1407–1414
Porco TC, Holbrook KA, Fernyak SE, Portnoy DL, Reiter R, Aragón TJ (2004) Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network model. BMC Public Health 4:34
Kretzschmar M, van den Hof S, Wallinga J, van Wijngaarden J (2004) Ring vaccination and smallpox control. Emerg Infect Dis 10(5):832–841
Wu JT, Riley S, Fraser C, Leung GM (2006) Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine 3:1532–1540
Hyman JM, Li J, Stanley EA (2003) Modeling the impact of random screening and contact tracing in reducing the spread of HIV. Math Biosci 181:17–54
Armbruster B, Brandeau ML (2007) Optimal mix of screening and contact tracing for endemic diseases. Math Biosci 209:386–402
Kretzschmar M (2000) Sexual network structure and sexually transmitted disease prevention: a modeling perspective. Sex Transm Dis 27:627–635
Müller J, Kretzschmar M, Dietz K (2000) Contact tracing in stochastic and deterministic epidemic models. Math Biosci 164:39–64
Huerta R, Tsimring LS (2002) Contact tracing and epidemics control in social networks. Phys Rev E Stat Nonlin Soft Matter Phys 66(5):56115
Eames KTD, Keeling MJ (2003) Contact tracing and disease control. Proc R Soc Lond B Biol Sci 270:2565–2571
Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D (2000) Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 162(6):2079–2086
Macintyre CR, Plant AJ, Hendrie D (2000) The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis. Health Econ 9(5):411–421
Varghese B, Peterman TA, Holtgrave DR (1999) Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS 13(13):1745–1751
Cohen DA, Wu SY, Farley TA (2004) Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr 37(3):1404–1414
Howell MR, Kassler WJ, Haddix A (1997) Partner notification to prevent pelvic inflammatory disease in women: cost-effectiveness of two strategies. Sex Transm Dis 24(5):287–292
Oxman GL, Doyle L (1996) A comparison of the case-finding effectiveness and average costs of screening and partner notification. Sex Transm Dis 23(1):51–57
Welte R, Kretzschmar M, Postma MJ, Leidl R, van den Hoek JAR, Jager JC, Postma MJ (2000) Cost-effectiveness of screening programs for chlamydia trachomatis: a population based dynamic approach. Sex Transm Dis 27:518–529
Watts DJ, Strogatz SH (1998) Collective dynamics of ‘small-world’ networks. Nature 393:440–442
Schneeberger A, Mercer CH, Gregson SA, Ferguson NM, Nyamukapa CA, Anderson RM, Johnson AM, Garnett GP (2004) Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis 31(6):380–387
Klovdahl AS, Potterat JJ, Woodhouse DE, Muth JB, Muth SQ, Darrow WW (1994) Social networks and infectious disease: the Colorado Springs study. Soc Sci Med 38(1):79–88
Weeks MR, Clair S, Borgatti SP, Radda K, Schensul JJ (2002) Social networks of drug users in high-risk sites: finding the connections. AIDS Behav 6(2):194–206
Parker M, Ward H, Day S (1998) Sexual networks and the transmission of HIV in London. J Biosoc Sci 30:63–83
Helleringer S, Kohler HP, Chimbiri A, Chatonda P, Mkandawire J (2007) The Likoma network study: context, data collection and survey instruments. URL: http://www.ssc.upenn.edu/~hpkohler/working-papers/hell06likdoc.pdf. Working paper
Wylie JL, Jolly A (2001) Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada. Sex Transm Dis 28(1):14–24
Armbruster B, Brandeau ML (2007) Who do you know? A simulation study of infectious disease control through contact tracing. In: Proceedings of the 2007 Western Multiconference on Computer Simulation, pp 79–85
Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in health and medicine. Oxford Univ. Press
National Institutes of Health (2001) Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. URL: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
Centers for Disease Control and Prevention (2006) Fact sheet: gonorrhea. URL: http://www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea.htm
Mehta SD, Bishai D, Howell MR, Rothman RE, Quinn TC, Zenilman JM (2002) Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sex Transm Dis 29(2):83–91
Centers for Disease Control and Prevention (2001) Program evaluation. URL: http://www.cdc.gov/std/program/training/TOC-PGtraining.htm
Neumann P, et al. (2001) Preference weights 1998–2001. URL: http://www.tufts-nemc.org/cearegistry/data/docs/phaseIIpreferenceweights.pdf
Owens DK (1998) Interpretation of cost-effectiveness analyses. J Gen Intern Med 13:716–717
U.S. Citizenship and Immigration Services (2006) Medical examinations. URL: http://www.uscis.gov/propub/ProPubVAP.jsp?dockey=1c56d78b831659735c9fd1c1f7dbd68f
Citizenship and Immigration Canada (2002) Fact sheet—medical testing and surveillance. URL: http://www.cic.gc.ca/english/pub/fs-medical.html
World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. URL: http://www.who.int/docstore/hiv/GRSTI/index.htm
Centers for Disease Control and Prevention (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 55(RR14):1–17
Webb AL (2004) But I didn’t know..., 2004. Philadelphia City Paper January 22
Centers for Disease Control and Prevention (2005) STD surveillance 2005 national profile—chlamydia. URL: http://www.cdc.gov/std/stats/chlamydia.htm
National Institutes of Health (2006) Chlamydia. URL: http://www.niaid.nih.gov/factsheets/stdclam.htm
Zimmerman HL, Potterat JJ, Dukes RL, Muth JB, Zimmerman HP, Fogle JS, Pratts CI (1990) Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health 80(11):1338–1342
Hu D, Hook EW 3rd, Goldie SJ (2004) Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med 141:501–513
Kaplan EH, Craft DL, Wein LM (2002) Emergency response to a smallpox attack: the case for mass vaccination. PNAS 99(16):10935–10940
Centers for Disease Control and Prevention (2007) Extensively drug-resistant tuberculosis—United States, 1993–2006. MMWR 56(11):250–253
Centers for Disease Control and Prevention (2007) Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR 56(14):332–336
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Armbruster, B., Brandeau, M.L. Contact tracing to control infectious disease: when enough is enough. Health Care Manage Sci 10, 341–355 (2007). https://doi.org/10.1007/s10729-007-9027-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10729-007-9027-6